Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation

International Immunopharmacology

Volumn 5, Issue 1, 2005, Pages 67-71

  Andersen, Johnny ^a   Heilmann, Carsten ^a   Jacobsen, Niels ^a   Bendtzen, Klaus ^a   Müller, Klaus ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Chemotherapy; Cyclophosphamide; Interleukins; Soluble tumour necrosis factor receptor I; Stem cell transplantation; Total body irradiation; Tumour necrosis factor

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P70; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; CASE REPORT; CHEMOTHERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RELIABILITY; WHOLE BODY RADIATION;

ADULT; ANTILYMPHOCYTE SERUM; CHILD; CYTOKINES; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATION; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 10344229912     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.09.021     Document Type: Article

References (17)

1. J.L.M. Ferrara, and J.H. Antin The pathophysiology of graft-versus-host disease Bone Marrow Transplant. 1999 305 315 [Forman]
2. F. Loberiza International Bone Marrow Transplant Registry Newsletter vol. 10 2003 7 10
3. E. Holler, H.J. Kolb, R. Hintermeier-Knabe, J. Mittermuller, and S. Thierfelder Role of tumour necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation Transplant. Proc. 25 1993 1234 1236
4. M. Remberger, O. Ringden, and L. Markling TNFα levels are increased during bone marrow transplantation conditioning in patients who develop acute GvHD Bone Marrow Transplant. 15 1995 99 104
5. P. Herve, M. Flesch, P. Tiberghien, J. Wijdenes, and E. Racadot Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease Blood 79 1992 3362 3368
6. E. Holler, H.J. Kolb, J. Mittermuller, M. Kaul, and G. Ledderose Modulation of graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing TNFα (MAK 195F) Blood 86 1995 890 899
7. A.N. Abdallah, J.M. Boiron, Y. Attia, A. Cassaigne, and J. Reiffers Plasma cytokines in graft versus host disease and complications following bone marrow transplantation Hematol. Cell Ther. 39 1997 27 32
8. R.C. Chasty, W.R. Lamb, H. Gallati, T.E. Roberts, and P.EC. Brenchley Serum cytokine levels in patients undergoing bone marrow transplantation Bone Marrow transplant. 12 1993 331 336
9. H. Takatsuka, Y. Takemoto, S. Yamada, H. Wada, and S. Tamura Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome Bone Marrow Transplant. 26 2000 419 426
10. O.S. Sardas, M. Beksac, H. Koc, O. Ilhan, and H. Akan Tumor necrosis factor alpha in human bone marrow recipients Blood 76 1990 2639 2640
11. S. Abhyankar, D.G. Gilliland, and J.L. Ferrara Interleukin-1 is a critical effector molecule during cytokine dysregulation and graft-versus-host disease to minor histocompatibility antigens Transplantation 56 1993 1518 1523
12. K.S. Baker, M.G. Roncarolo, C. Peters, M. Bigler, and T. Defor High spontaneous IL-10 production in unrelated bone marrow transplant recipient is associated with fewer transplant-related complications and early death Bone Marrow Transplant. 23 1999 1123 1129
13. E. Holler, M.G. Roncarolo, R. Hintermeyer-Knabe, G. Eussner, and B. Ertl Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation Bone Marrow Transplant. 25 2000 237 241
14. J.H. Antin, H.J. Weinstein, E.C. Guinan, P. McCarthy, and B.E. Bierer Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease Blood 84 1994 1342 1348
15. L.S. Andersen, J. Petersen, and K. Bendtzen Production of interleukin (IL)-1b, IL-1 receptor antagonist and IL-10 by mononuclear cells in chronic arthritis Cytokine 12 2000 62 68
16. K. Bendtzen Cytokines and natural regulators of cytokines Immunol. Lett. 43 1994 111 123
17. C.A. Dinarello, and R.C. Thompson Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro Immunol. Today 12 1991 404 410